deferoxamine mesylate
Generic: deferoxamine mesylate
Labeler: apotex corp.Drug Facts
Product Profile
Brand Name
deferoxamine mesylate
Generic Name
deferoxamine mesylate
Labeler
apotex corp.
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
deferoxamine mesylate 2 g/1
Manufacturer
Identifiers & Regulatory
Product NDC
60505-6237
Product ID
60505-6237_f4fed4ee-e8e9-1570-7c55-faa115e27751
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207384
Listing Expiration
2026-12-31
Marketing Start
2021-11-05
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
605056237
Hyphenated Format
60505-6237
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
deferoxamine mesylate (source: ndc)
Generic Name
deferoxamine mesylate (source: ndc)
Application Number
ANDA207384 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 g/1
Packaging
- 4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (60505-6237-6)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "f4fed4ee-e8e9-1570-7c55-faa115e27751", "openfda": {"unii": ["V9TKO7EO6K"], "rxcui": ["1731345", "1731350"], "spl_set_id": ["c99553fb-3fae-b88a-6c2c-efa7520197f9"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (60505-6237-6)", "package_ndc": "60505-6237-6", "marketing_start_date": "20211105"}], "brand_name": "Deferoxamine mesylate", "product_id": "60505-6237_f4fed4ee-e8e9-1570-7c55-faa115e27751", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Iron Chelating Activity [MoA]", "Iron Chelator [EPC]"], "product_ndc": "60505-6237", "generic_name": "Deferoxamine mesylate", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Deferoxamine mesylate", "active_ingredients": [{"name": "DEFEROXAMINE MESYLATE", "strength": "2 g/1"}], "application_number": "ANDA207384", "marketing_category": "ANDA", "marketing_start_date": "20211105", "listing_expiration_date": "20261231"}